Effect of evidence based risk information on "informed choice" in colorectal cancer screening: randomised controlled trial
- PMID: 21636633
- PMCID: PMC3106362
- DOI: 10.1136/bmj.d3193
Effect of evidence based risk information on "informed choice" in colorectal cancer screening: randomised controlled trial
Abstract
Objective: To compare the effect of evidence based information on risk with that of standard information on informed choice in screening for colorectal cancer.
Design: Randomised controlled trial with 6 months' follow-up.
Setting: German statutory health insurance scheme.
Participants: 1577 insured people who were members of the target group for colorectal cancer screening (age 50-75, no history of colorectal cancer).
Interventions: Brochure with evidence based risk information on colorectal cancer screening and two optional interactive internet modules on risk and diagnostic tests; official information leaflet of the German colorectal cancer screening programme (control).
Main outcome measure: The primary end point was "informed choice," comprising "knowledge," "attitude," and "combination of actual and planned uptake." Secondary outcomes were "knowledge" and "combination of actual and planned uptake." Knowledge and attitude were assessed after 6 weeks and combination of actual and planned uptake of screening after 6 months.
Results: The response rate for return of both questionnaires was 92.4% (n = 1457). 345/785 (44.0%) participants in the intervention group made an informed choice, compared with 101/792 (12.8%) in the control group (difference 31.2%, 99% confidence interval 25.7% to 36.7%; P < 0.001). More intervention group participants had "good knowledge" (59.6% (n = 468) v 16.2% (128); difference 43.5%, 37.8% to 49.1%; P < 0.001). A "positive attitude" towards colorectal screening prevailed in both groups but was significantly lower in the intervention group (93.4% (733) v 96.5% (764); difference -3.1%, -5.9% to -0.3%; P<0.01). The intervention had no effect on the combination of actual and planned uptake (72.4% (568) v 72.9% (577); P = 0.87).
Conclusions: Evidence based risk information on colorectal cancer screening increased informed choices and improved knowledge, with little change in attitudes. The intervention did not affect the combination of actual and planned uptake of screening. Trial registration Current Controlled Trials ISRCTN47105521.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Similar articles
-
A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial.BMJ. 2010 Oct 26;341:c5370. doi: 10.1136/bmj.c5370. BMJ. 2010. PMID: 20978060 Free PMC article. Clinical Trial.
-
[Effect of Evidence-Based Risk Information on "Informed Choice" in Colorectal Cancer Screening: Randomised Controlled Trial].Gesundheitswesen. 2015 Sep;77 Suppl 1:S93-4. doi: 10.1055/s-0032-1329999. Epub 2013 Apr 3. Gesundheitswesen. 2015. PMID: 23553186 Clinical Trial. German.
-
The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS)-a randomised controlled trial.BMC Med. 2020 Oct 20;18(1):285. doi: 10.1186/s12916-020-01750-3. BMC Med. 2020. PMID: 33076932 Free PMC article.
-
The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.BMC Public Health. 2019 Apr 16;19(1):411. doi: 10.1186/s12889-019-6734-0. BMC Public Health. 2019. PMID: 30991987 Free PMC article.
-
Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.Cochrane Database Syst Rev. 2020 Mar 12;3(3):CD009498. doi: 10.1002/14651858.CD009498.pub4. Cochrane Database Syst Rev. 2020. PMID: 32163181 Free PMC article.
Cited by
-
Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).Health Expect. 2015 Oct;18(5):839-49. doi: 10.1111/hex.12056. Epub 2013 Feb 25. Health Expect. 2015. PMID: 23432931 Free PMC article.
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6. Cochrane Database Syst Rev. 2024. PMID: 38284415 Free PMC article.
-
Personalised risk communication for informed decision making about taking screening tests.Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD001865. doi: 10.1002/14651858.CD001865.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450534 Free PMC article.
-
Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation.Br J Cancer. 2012 Dec 4;107(12):1938-43. doi: 10.1038/bjc.2012.512. Epub 2012 Nov 22. Br J Cancer. 2012. PMID: 23175148 Free PMC article.
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2017 Apr 12;4(4):CD001431. doi: 10.1002/14651858.CD001431.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2024 Jan 29;1:CD001431. doi: 10.1002/14651858.CD001431.pub6. PMID: 28402085 Free PMC article. Updated.
References
-
- Eggen D, Stein R. Mammograms and politics: task force stirs up a tempest. Washington Post. 18 November 2009.
-
- Gøtzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jørgensen KJ. Breast screening: the facts—or maybe not. BMJ 2009;338:b86. - PubMed
-
- Felix Burda Foundation. Campaign 2010. www.felix-burda-stiftung.de/kampagne-2011/index.php.
-
- Bekker HL. Decision aids and uptake of screening. BMJ 2010;341:c5407. - PubMed
-
- Steckelberg A, Berger B, Köpke S, Heesen C, Mühlhauser I. [Criteria for evidence-based patient information] [German]. Z Arztl Fortbild Qualitatssich 2005;99:343-51. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical